Nurse Practitioner · Detroit, MI
NPI
1922129055
Since 2007
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3031 W Grand Blvd, Department of Obgyn
Detroit, MI, 48202
Phone (313) 916-2454
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,588
46 services
Medicare patients, 2024
35
Average age 67
Drug cost, 2024
$217K
76 prescriptions
Company payments, 2025
$493
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura M Gusba was code 38222 (other organ systems), 18 times for 17 patients. In total Laura M Gusba billed 46 services in 11 codes, and Medicare paid $2,588.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 38222 Other Organ Systems | Facility | 18 | 17 | $50.96 | $917 |
By year: 2022 $2,399 for 41 services; 2023 $2,675 for 40 services; 2024 $2,588 for 46 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura M Gusba prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 13 prescriptions and refills. In total Laura M Gusba wrote 76 Medicare prescriptions that cost $217K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 13 | 13 | Under 11 | $75.07 |
| Vpriv Velaglucerase Alfa | 11 | 11 | Under 11 | $170K |
Brand drugs: 20 claims; generic drugs: 56 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura M Gusba $493 ($493 in general payments such as food, travel and fees) from 3 companies. The largest payer was Genzyme Corporation with $300.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.